Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.

Brown L, Eum S, Haga SB, Strawn JR, Zierhut H.

Pharmacopsychiatry. 2019 Sep 11. doi: 10.1055/a-0975-9595. [Epub ahead of print]

PMID:
31509860
2.

A Physiological Marriage Made in Heaven: Treating and Measuring the Brain Through Stimulation.

Daskalakis ZJ, Tyndale RF.

Clin Pharmacol Ther. 2019 Oct;106(4):691-695. doi: 10.1002/cpt.1576. No abstract available.

PMID:
31509631
3.

Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation.

Hernandez W, Danahey K, Pei X, Yeo KJ, Leung E, Volchenboum SL, Ratain MJ, Meltzer DO, Stranger BE, Perera MA, O'Donnell PH.

Pharmacogenomics J. 2019 Sep 11. doi: 10.1038/s41397-019-0095-z. [Epub ahead of print]

PMID:
31506565
4.

Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.

Labriet A, Lévesque É, Cecchin E, De Mattia E, Villeneuve L, Rouleau M, Jonker D, Couture F, Simonyan D, Allain EP, Buonadonna A, D'Andrea M, Toffoli G, Guillemette C.

Sci Rep. 2019 Sep 10;9(1):13008. doi: 10.1038/s41598-019-49477-3.

5.

Application of Chinese Medicine in Acute and Critical Medical Conditions.

Luo Y, Wang CZ, Hesse-Fong J, Lin JG, Yuan CS.

Am J Chin Med. 2019 Sep 10:1-13. doi: 10.1142/S0192415X19500629. [Epub ahead of print]

PMID:
31505937
6.

Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.

Gutierrez-Camino Á, Umerez M, Lopez-Lopez E, Santos-Zorrozua B, Martin-Guerrero I, de Andoin NG, Ana S, Navajas A, Astigarraga I, Garcia-Orad A.

Pharmacogenomics. 2018 Dec;19(18):1403-1412. doi: 10.2217/pgs-2018-0113.

PMID:
30479191
7.

Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors.

Chen LS, Hartz SM, Baker TB, Ma Y, L Saccone N, Bierut LJ.

Pharmacogenomics. 2018 Dec;19(18):1383-1394. doi: 10.2217/pgs-2018-0081. Epub 2018 Nov 16.

PMID:
30442082
8.

Genetic polymorphism contributes to 131I radiotherapy-induced toxicities in patients with differentiated thyroid cancer.

Liu J, Tang X, Shi F, Li C, Zhang K, Liu J, Wang G, Yin J, Li Z.

Pharmacogenomics. 2018 Nov;19(17):1335-1344. doi: 10.2217/pgs-2018-0070. Epub 2018 Oct 16.

PMID:
30430914
9.

Breakthrough cancer genome analysis in time and space: novel oncotargets and early drug development.

Kyrochristos ID, Ziogas DE, Antoniou P, Mitsis M, Lykoudis EG, Roukos DH.

Pharmacogenomics. 2018 Nov;19(17):1303-1310. doi: 10.2217/pgs-2018-0141. Epub 2018 Oct 23. No abstract available.

PMID:
30348059
10.

Impact of UGT2B7 and ABCC2 genetic polymorphisms on mycophenolic acid metabolism in Chinese renal transplant recipients.

Li LQ, Chen DN, Li CJ, Li QP, Chen Y, Fang P, Zheng P, Lu HJ, Ye DM, Wan HY, Li J, Li L.

Pharmacogenomics. 2018 Nov;19(17):1323-1334. doi: 10.2217/pgs-2018-0114. Epub 2018 Oct 22.

PMID:
30345879
11.

RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Isackson PJ, Wang J, Zia M, Spurgeon P, Levesque A, Bard J, James S, Nowak N, Lee TK, Vladutiu GD.

Pharmacogenomics. 2018 Nov;19(16):1235-1249. doi: 10.2217/pgs-2018-0106. Epub 2018 Oct 16.

PMID:
30325262
12.

Using genomics to guide treatment for glioblastoma.

Young JS, Prados MD, Butowski N.

Pharmacogenomics. 2018 Oct;19(15):1217-1229. doi: 10.2217/pgs-2018-0078. Epub 2018 Sep 11. Review.

PMID:
30203716
13.

Late stent thrombosis in a patient with CYP2C19*3/*17 genotype and clopidogrel high on-treatment platelet reactivity.

Tan SSN, Koh KT, Tiong LL, Ong TK, Fong AYY.

Pharmacogenomics. 2018 Oct;19(15):1151-1157. doi: 10.2217/pgs-2018-0082. Epub 2018 Sep 7.

PMID:
30191759
14.

Glucocorticoid receptor single nucleotide polymorphisms are associated with acute crisis pain in sickle cell disease.

Jhun EH, Sadhu N, Yao Y, He Y, Molokie RE, Wilkie DJ, Wang ZJ.

Pharmacogenomics. 2018 Aug 1;19(13):1003-1011. doi: 10.2217/pgs-2018-0064. Epub 2018 Aug 6.

15.

Human liver spheroids in chemically defined conditions for studies of gene-drug, drug-drug and disease-drug interactions.

Ingelman-Sundberg M, Lauschke VM.

Pharmacogenomics. 2018 Sep 1;19(14):1133-1138. doi: 10.2217/pgs-2018-0096. Epub 2018 Jul 25.

PMID:
30041575
16.

Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.

Raimondi A, Nichetti F, Peverelli G, Di Bartolomeo M, De Braud F, Pietrantonio F.

Pharmacogenomics. 2018 Aug 1;19(13):1047-1068. doi: 10.2217/pgs-2018-0077. Epub 2018 Jul 25. Review.

PMID:
30041572
17.

Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients.

Zhu W, Xue L, Peng H, Duan Z, Zheng X, Cao D, Wen J, Wei X.

Pharmacogenomics. 2018 Aug 1;19(13):1013-1025. doi: 10.2217/pgs-2017-0139. Epub 2018 Jul 24.

PMID:
30040022
18.

Association of ABCC2  polymorphism and gender with high-density lipoprotein cholesterol response to simvastatin.

Liu N, Yang G, Hu M, Cai Y, Hu Z, Jia C, Zhang M.

Pharmacogenomics. 2018 Sep 1;19(14):1125-1132. doi: 10.2217/pgs-2018-0084. Epub 2018 Jul 19.

PMID:
30024814
19.

Effect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplay.

Sim S, Lövrot J, Lindh JD, Bergh J, Xie H.

Pharmacogenomics. 2018 Aug 1;19(13):1027-1037. doi: 10.2217/pgs-2018-0089. Epub 2018 Jul 19.

PMID:
30022682
20.

Randomized controlled trials in pediatric patients had higher completion rates than adult trials: a cross-sectional study.

Dufetelle E, 't Jong GW, Kaguelidou F.

J Clin Epidemiol. 2018 Aug;100:53-60. doi: 10.1016/j.jclinepi.2018.04.018. Epub 2018 Apr 26.

PMID:
29705092

Supplemental Content

Loading ...
Support Center